First patient enrolled in phase III FALCON trial of bardoxolone for the treatment of AKPKD May 31, 2019
Phase III KALM-1 study of Korsuva in hemodialysis patients with pruritus meets primary endpoint May 30, 2019
Gilead and Goldfinch Bio enter strategic collaboration to develop novel therapies for kidney disease May 10, 2019
RSS